Company intelligence / Profile preview

Valpharma

Ownership: Private
Development stage: Commercial

Overview

Valpharma has over 40 years of experience in pharmaceutical development and contract manufacturing of solid oral dosage medicines and nutraceuticals. It is recognized for its expertise in modified-release formulations that optimize dosing regimens for improved efficacy and reduced side effects. The group supplies products globally across more than 70 countries.

Therapeutic areas: GastroenterologyCardiovascularEndocrinologyNeurology
Modalities: Small moleculeBiologicNutraceuticals
Industry: Contract Manufacturing Organization

Partnerships

Not explicitly listed; as a CDMO/CMO they partner with numerous global pharma companies on contract manufacturing projects

Beyond the preview

Go deeper on Valpharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Valpharma.

Explore the full profile